Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2016
Filed with the SEC on Jul 29, 2016 and accepted by EDGAR at Jul 29, 2016, 13:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 12 months2015-05-01 to 2016-04-30 | $4.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2015-05-01 to 2016-04-30 | −$10.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2015-05-01 to 2016-04-30 | $92.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2015-05-01 to 2016-04-30 | −$10.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2015-05-01 to 2016-04-30 | −$1.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2015-05-01 to 2016-04-30 | −$1.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2015-05-01 to 2016-04-30 | 8,695,199 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2015-05-01 to 2016-04-30 | −$6.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2015-05-01 to 2016-04-30 | $322.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-04-30 | $2.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-04-30 | $4.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-04-30 | $5.8m | us-gaap:Assets |
| Current liabilities | At period end2016-04-30 | $5.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-04-30 | $5.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-04-30 | $238.0k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-16-017936. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.